Literature DB >> 16604518

Generation of a mouse with conditionally activated signaling through the BMP receptor, ALK2.

Tomokazu Fukuda1, Gregory Scott, Yoshihiro Komatsu, Runa Araya, Masako Kawano, Manas K Ray, Masahisa Yamada, Yuji Mishina.   

Abstract

BMP signaling plays pleiotropic roles in various tissues. Transgenic mouse lines that overexpress BMP signaling in a tissue-specific manner would be beneficial; however, production of each tissue-specific transgenic mouse line is labor-intensive. Here, using a Cre-loxP system, we generated a conditionally overexpressing mouse line for BMP signaling through the type I receptor ALK2 (alternatively known as AVCRI, ActRI, or ActRIA). By mating this line with Cre-expression mouse lines, Cre-mediated recombination removes an intervening floxed lacZ expression cassette and thereby permits the expression of a constitutively active form of Alk2 (caAlk2) driven by a ubiquitous promoter, CAG. Tissue specificity of Cre recombination was monitored by a bicistronically expressed EGFP following Alk2 cDNA. Increased BMP signaling was confirmed by ectopic phosphorylation of SMAD1/5/8 in the areas where Cre recombination had occurred. The conditional overexpression system described here provides versatility in investigating gene functions in a tissue-specific manner without having to generate independent tissue-specific transgenic lines. Published 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16604518     DOI: 10.1002/dvg.20201

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  65 in total

1.  AcvR1-mediated BMP signaling in second heart field is required for arterial pole development: implications for myocardial differentiation and regional identity.

Authors:  Penny S Thomas; Sudha Rajderkar; Jamie Lane; Yuji Mishina; Vesa Kaartinen
Journal:  Dev Biol       Date:  2014-03-27       Impact factor: 3.582

2.  BMP signaling mediated by constitutively active Activin type 1 receptor (ACVR1) results in ectopic bone formation localized to distal extremity joints.

Authors:  Shailesh Agarwal; Shawn J Loder; Cameron Brownley; Oluwatobi Eboda; Jonathan R Peterson; Satoru Hayano; Bingrou Wu; Bin Zhao; Vesa Kaartinen; Victor C Wong; Yuji Mishina; Benjamin Levi
Journal:  Dev Biol       Date:  2015-02-23       Impact factor: 3.582

Review 3.  Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva.

Authors:  Kelly L Wentworth; Umesh Masharani; Edward C Hsiao
Journal:  Br J Clin Pharmacol       Date:  2019-01-06       Impact factor: 4.335

Review 4.  The balance of tissue repair and remodeling in chronic arthritis.

Authors:  Rik Lories
Journal:  Nat Rev Rheumatol       Date:  2011-10-18       Impact factor: 20.543

5.  Investigations of activated ACVR1/ALK2, a bone morphogenetic protein type I receptor, that causes fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Petra Seemann; Julia Haupt; Meiqi Xu; Vitali Y Lounev; Mary Mullins; Eileen M Shore
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

Review 6.  Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.

Authors:  Emilie Barruet; Edward C Hsiao
Journal:  Bone       Date:  2017-07-14       Impact factor: 4.398

7.  Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.

Authors:  Maiko Omi; Vesa Kaartinen; Yuji Mishina
Journal:  J Biol Chem       Date:  2019-10-16       Impact factor: 5.157

8.  ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant.

Authors:  Julia Haupt; Alexandra Deichsel; Katja Stange; Cindy Ast; Renata Bocciardi; Roberto Ravazzolo; Maja Di Rocco; Paola Ferrari; Antonio Landi; Frederick S Kaplan; Eileen M Shore; Carsten Reissner; Petra Seemann
Journal:  Hum Mol Genet       Date:  2014-05-22       Impact factor: 6.150

Review 9.  Stem cells and heterotopic ossification: Lessons from animal models.

Authors:  John B Lees-Shepard; David J Goldhamer
Journal:  Bone       Date:  2018-01-31       Impact factor: 4.398

10.  Mapping mouse hemangioblast maturation from headfold stages.

Authors:  Jerry M Rhee; Philip M Iannaccone
Journal:  Dev Biol       Date:  2012-02-24       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.